Iovance Biotherapeutics Inc (NAS:IOVA)
$ 7.78 -0.36 (-4.42%) Market Cap: 2.18 Bil Enterprise Value: 2.01 Bil PE Ratio: 0 PB Ratio: 3.20 GF Score: 35/100

Iovance Biotherapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2020 / 06:15PM GMT
Release Date Price: $39.16 (-3.17%)
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

Hello. Welcome back, everybody. It's not quite the same being -- and we're not in Scottsdale together, so I can't really see the audience. But welcome to the first day, the afternoon sessions of the Crédit Suisse Global Virtual Healthcare Conference. Hopefully, it's in-person next year.

And with me today, I have Iovance. And from Iovance, I have Maria Fardis. Maria, I believe you have a presentation, then we might take some questions at the end. So I'm going to now pass the reigns over to you.

Maria Fardis
Iovance Biotherapeutics, Inc. - CEO, President & Director

That's perfect. Thank you so much. Good afternoon, everyone. Thank you for the opportunity to speak before you today. I will share some of our slides with you, if I can figure out how to open it.

Apologies, I'm not able to open it. Sara, are you able to open the slides? We were not having these issues earlier today, but we're having issues in opening

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot